University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Gefitinib and Methotrexate to Treat Ectopic Pregnancies with a Pre-Treatment Serum hCG 1000–10,000 IU/L : Phase II Open Label, Single Arm Multi-Centre Trial

Simple item page
dc.contributor.authorSkubisz, Monika M.
dc.contributor.authorTong, Stephen
dc.contributor.authorDoust, Ann
dc.contributor.authorMollison, Jill
dc.contributor.authorJohns, Terrance G.
dc.contributor.authorNeil, Peter
dc.contributor.authorRobinson, Miranda
dc.contributor.authorBhattacharya, Siladitya
dc.contributor.authorWallace, Euan
dc.contributor.authorKrzys, Nicole
dc.contributor.authorColin Duncan, W.
dc.contributor.authorHorne, Andrew W.
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2018-07-30T09:33:08Z
dc.date.available2018-07-30T09:33:08Z
dc.date.issued2018-07
dc.descriptionThis work was supported by an NHMRC Grant (#1008276) to ST, TJ and EW, and an MRC Centenary Award (G0802808) to AH. The funders had no role study design, collection, analysis, and interpretation of data; in the writing of the report or in the decision to submit the paper.en
dc.description.statusPeer revieweden
dc.format.extent6
dc.format.extent602597
dc.identifier130181847
dc.identifier9ae71dd6-3a67-47ca-8893-4da701ba3065
dc.identifier85048938616
dc.identifier.citationSkubisz, M M, Tong, S, Doust, A, Mollison, J, Johns, T G, Neil, P, Robinson, M, Bhattacharya, S, Wallace, E, Krzys, N, Colin Duncan, W & Horne, A W 2018, 'Gefitinib and Methotrexate to Treat Ectopic Pregnancies with a Pre-Treatment Serum hCG 1000–10,000 IU/L : Phase II Open Label, Single Arm Multi-Centre Trial', EBioMedicine, vol. 33, pp. 276-281. https://doi.org/10.1016/j.ebiom.2018.06.017en
dc.identifier.doi10.1016/j.ebiom.2018.06.017
dc.identifier.issn2352-3964
dc.identifier.otherORCID: /0000-0002-4588-356X/work/159509575
dc.identifier.urihttp://hdl.handle.net/2164/10826
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85048938616&partnerID=8YFLogxKen
dc.identifier.vol33en
dc.language.isoeng
dc.relation.ispartofEBioMedicineen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectEctopic pregnancyen
dc.subjectGefitiniben
dc.subjectMedical treatmenten
dc.subjectMethotrexateen
dc.subjectPhase IIen
dc.subjectR Medicineen
dc.subjectGeneral Biochemistry,Genetics and Molecular Biologyen
dc.subjectMedical Research Council (MRC)en
dc.subjectG0802808en
dc.subject.lccRen
dc.titleGefitinib and Methotrexate to Treat Ectopic Pregnancies with a Pre-Treatment Serum hCG 1000–10,000 IU/L : Phase II Open Label, Single Arm Multi-Centre Trialen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Gefitinib_and_Methotrexate_to_Treat_Ectopic_Pregnancies_with_a_Pre_Treatment_Serum_hCG_1000_10_000_IUL_Phase_II_Open_Label_Single_Arm_Multi_Centre_Trial.pdf
Size:
588.47 KB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.29 KB
Format:
Plain Text
Description:
Download

Collections

All research
Applied Health Sciences research
University Office research